"The fundamentals have always been strong, but we are seeing increased understanding that biotech companies are in fact commercializing medical research, and that is contingent upon the entire ecosystem functioning well. We have seen an expressed intention from government to grow innovation, and the sector clearly has the potential to lead Australia's transition to an innovation-based economy." Glenn Cross, AusBiotech CEO, commenting on a survey of Australian biotech CEOs compiled by consulting firm Grant Thornton